
Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.
Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers
Education and Training
- Fellowship, Urologic Oncology, Mayo Clinic, 2005 - 2008
- Residency, Urology, Universite Laval (Canada), 2001 - 2005
- M.S., Mayo Clinic, Alix School of Medicine, 2011
- M.D., University of Alberta (Canada), 2000
- B.S., University of Alberta (Canada), 1999
In the News
Selected Grants
- PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY BLADDER CANCER
- Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Altera
- Duke CTSA (TL1)
- Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer
- A PHASE Ib/II, OPEN-LABEL STUDY OF THE SAFETY AND PHARMACOLOGY OF ATEZOLIZUMAB ADMINISTERED WITH OR WITHOUT BACILLE CALMETTE-GUÉRIN IN PATIENTS WITH HIGH-RISK NON¿MUSCLEINVASIVE BLADDER CANCER
- A Canine Model for Human High-Risk Non-Muscle Invasive Human Bladder Cancer-Molecular and Environmental Considerations
- Translational Research in Surgical Oncology
- The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
A Multicenter, Prospective Blinded Pivotal Study - TAR-200 Study
- Synergistic Immuno-Photo-Nanotherapy for Bladder Cancer
- Therapeutic targeting of B7-H3 to reverse prostate cancer treatment resistance.
- Heat Targeted Therapy for Bladder Cancer
- A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder C
- BMS Bladder and Prostate Practicum 2019
- Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder
- A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel on Ablation of Upper Urinary Tract Urothelial Carcinoma
- Pig Bladder Hyperthermia Testing Device
- Bladder Tumor TURBT Study
- Phase II Trial of Aerobic Training in Metastatic Breast Cancer
- Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer